| 000 | 00601nam a2200169Ia 4500 | ||
|---|---|---|---|
| 008 | 190328s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a92-4-120843-0 | ||
| 040 |
_aNITIL _cNITIL |
||
| 082 |
_221st _a616.716 _bW927A |
||
| 110 | _aWorld Health Organization (Geneva) | ||
| 245 | 0 |
_aAssessment of fracture risk and its application to screening for postmenopausal teoporosis _breport of a WHO study group |
|
| 260 |
_aGeneva _bWHO _c1994 |
||
| 300 | _av, 129p. | ||
| 440 | _aWHO technical report series; 843 | ||
| 650 | _aOsteoporosis; Bone-Diseases; Fractures; Estragen-Therapeautic use | ||
| 942 | _cBKS | ||
| 999 |
_c28660 _d28660 |
||